Mindplex Mindplex
magazinepodcastnewstopicscommunitymindbytes
Sign in Sign up Create account

Topics

Follow the subjects shaping intelligence, science, culture, and the future of technology.

Browse topics

Find a subject, then follow its latest reporting and ideas.

3D Printing Acoustic Advanced tech for developing world Aged Care AGI Aging and Longevity Agriculture AI AI Takeover Algorithms Aliens Angel Investor Architecture Art Astrobiology Astronomy Augmented Reality Bacteria and Virus Beneficial General Intelligence Big Bang Theory Big Data Big Tech Biodiversity Biofuels

#AIInClinicalTrials

Recent stories, interviews, and analysis in this subject.

InnoCare Advances Vitiligo Drug After Phase 2 Result
Mindbytes Jul 16, 2026

InnoCare Advances Vitiligo Drug After Phase 2 Result

InnoCare's TYK2 inhibitor soficitinib hits vitiligo Phase 2 endpoint, advancing to Phase 3. Competitive autoimmune skin disorder trial shows strong F-VASI improvement.

Linsey 1 min read
The First AI-Discovered Drug Just Entered Phase III Trials. Here Is What That Means.
News Jul 8, 2026

The First AI-Discovered Drug Just Entered Phase III Trials. Here Is What That Means.

An AI-designed drug has entered Phase III trials, bringing the pharmaceutical industry closer to its first medicine invented entirely by artificial intelligence.

GizmoGuru 2 min read

Mindplex

AI, media, and community intelligence.

Mindplex brings together futurist writing, social discussion, and emerging AI tools for readers and builders tracking what comes next.

Explore

MagazinePodcastNews

Community

Community HubContributeModeratorsWriters & Editors

Resources

About UsFAQSearchTerms & Privacy

Connect

Contact UsPrivacy Policy

© 2026 MindPlex. All rights reserved

Terms Privacy
  • magazine
  • news
  • podcast
  • topics
  • community